Surgery for cataracts in people with age-related macular degeneration

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 2, 2017, Pages

  Casparis, Heather ^a   Lindsley, Kristina ^b   Kuo, Irene C ^c   Sikder, Shameema ^d   Bressler, Neil M ^d  

^a Ophthalmology   (Switzerland)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENCE OF COMPLICATIONS; AGE RELATED MACULAR DEGENERATION; AUSTRIA; BEST CORRECTED VISUAL ACUITY; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; DRUSEN; GEOGRAPHIC ATROPHY; HUMAN; META ANALYSIS; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ADVERSE EFFECTS; COMPLICATION; DISEASE COURSE; MACULAR DEGENERATION; MIDDLE AGED; PATHOLOGY; TIME FACTOR; VISUAL ACUITY;

CATARACT; CATARACT EXTRACTION; DISEASE PROGRESSION; HUMANS; MACULAR DEGENERATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; VISUAL ACUITY;

EID: 85013040938     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006757.pub4     Document Type: Review

References (67)

1. Brunner S, Krebs I, Stolba U, Falkner CI, Binder S, Bauer P. Cataract surgery in nonexudative age-related macular degeneration - first results of a prospective, randomized, multicenter trial (ECAM-1). Investigative Ophthalmology & Visual Science 2005; Vol. 46:ARVO E-abstract 195. [5086701]
2. Brunner S, Mora A, Fonseca J, Weber T, Falkner-Radler CI, Oeser R, et al. Monitoring of drusen and geographic atrophy area size after cataract surgery using the MD3RI tool for computer-aided contour drawing. Ophthalmologica 2013;229(2):86-93. [5086702]
3. Brunner S, Stolba U, Abri A, Falkner C, Manivannan A, Bauer P, et al. Does extracapsular cataract surgery influence the course in age-related macular degeneration (ECAM)? A short report of an ongoing clinical study [Beeinflusst eine extrakapsuläre kataraktextraktion den verlauf der altersabhängigen makuladegeneration (EKAM) ? - darstellung einer anlaufenden studie]. Spektrum der Augenheilkunde 2001;15(5):178-80. [5086703]
4. Hooper CY, Lamoureux EL, Lim L, Fraser-Bell S, Yeoh J, Harper CA, et al. Cataract surgery in high-risk age-related macular degeneration: a randomized controlled trial. Clinical and Experimental Ophthalmology 2009;37(6):570-6. [2672131]
5. Lamoureux EL, Hooper CY, Lim L, Pallant JF, Hunt N, Keeffe JE, et al. Impact of cataract surgery on quality of life in patients with early age-related macular degeneration. Optometry and Vision Science 2007;84(8):683-8. [2672132]
6. Albrecht S. Age-related macular degeneration. U.S. Pharmacist 2010;35(4):26-33. [2672134]
7. Armbrecht AM, Findlay C, Kaushal S, Aspinall P, Hill AR, Dhillon B. Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. British Journal of Ophthalmology 2000;84(12):1343-8. [2672136]
8. Chew EY. Is cataract surgery justified in patients with age-related macular degeneration?. Evidence-Based Eye Care 2001;2(3):136-7. [2672137]
9. Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B. Cataract surgery in patients with age-related macular degeneration: one-year outcomes. Journal of Cataract and Refractive Surgery 2003;29(4):686-93. [2672139]
10. Benson WB. Risk of advanced age-related macular degeneration after cataract surgery in the age-related eye disease study: AREDS report 25. Evidence-Based Ophthalmology 2009;10(3):158-9. [2672141]
11. Brown GC, Brown MM. Made to order. Evidence-Based Ophthalmology 2008;9(3):158-9. [2672143]
12. Grasso CM. Cataract extraction with multifocal intraocular lens implantation. Evidence-Based Eye Care 2001;2(3):138-9. [2672145]
13. Javitt JC, Steinert RF. Cataract extraction with multifocal intraocular lens implantation: a multinational clinical trial evaluating clinical, functional, and quality-of-life outcomes. Ophthalmology 2000;107(11):2040-8. [2672146]
14. Kertes PJ. Cataract surgery and quality of life in patients with age-related macular degeneration. Evidence-Based Eye Care 2003;4(2):110-1. [2672148]
15. Lundström M, Brege KG, Florén I, Lundh B, Stenevi U, Thorburn W. Cataract surgery and quality of life in patients with age related macular degeneration. British Journal of Ophthalmology 2002;86(12):1330-5. [2672149]
16. Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 1996;103(10):1546-54. [2672151]
17. Pollack A, Bukelman A, Zalish M, Leiba H, Oliver M. The course of age-related macular degeneration following bilateral cataract surgery. Ophthalmic Surgery and Lasers 1998;29(4):286-94. [2672153]
18. Prajna NV, Chandrakanth KS, Kim R, Narendran V, Selvakumar S, Rohini G, et al. The Madurai Intraocular Lens Study II: Clinical outcomes. American Journal of Ophthalmology 1998;125(1):14-25. [2672155]
19. Rohart C, Fajnkuchen F, Nghiem-Buffet S, Abitbol O, Badelon I, Chaine G. Cataract surgery and age-related maculopathy: benefits in terms of visual acuity and quality of life - a prospective study [Chirurgie de la cataracte et degenerescence maculaire liee a l'age: benefice en termes d'acuite visuelle et de qualite de vie - etude prospective]. Journal Francais d' Ophtalmologie 2008;31(6 Pt 1):571-7. [2672157]
20. Rosen E, Rubowitz A, Assia EI. Visual outcome following cataract extraction in patients aged 90 years and older. Eye 2009;23(5):1120-4. [2672159]
21. Talukder AK, Bhuiyan SI, Zakia S, Hussain MI. Impaired visual outcome after cataract surgery. Mymensingh Medical Journal 2009;18(1 Suppl):S15-9. [2672161]
22. Zhao J, Ellwein LB, Cui H, Ge J, Guan H, Lv J, et al. Prevalence and outcomes of cataract surgery in rural China: the China nine-province survey. Ophthalmology 2010;117(11):2120-8. [2672163]
23. American Academy of Ophthalmology Cataract, Anterior Segment Panel. Preferred Practice Pattern® Guidelines. Cataract in the adult eye. www.aao.org/ppp 2016 (accessed prior to 5 February 2017).
24. Ang M, Evans JR, Mehta JS. Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD008811]
25. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000;107(12):2224-32.
26. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Archives of Ophthalmology 2001;119(10):1471-536.
27. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Survey of Ophthalmology 1995;39(5):367-74.
28. Bockelbrink A, Roll S, Ruether K, Rasch A, Greiner W, Willich SN. Cataract surgery and the development or progression of age-related macular degeneration: a systematic review. Survey of Ophthalmology 2008;53(4):359-67.
29. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. New England Journal of Medicine 2006;355(14):1432-44.
30. Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen NV. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmologica Scandinavica 2005;83(4):409-18.
31. CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. New England Journal of Medicine 2011;364(20):1897-908.
32. Chew EY, Sperduto RD, Milton RC, Clemons TE, Gensler GR, Bressler SB, et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. Ophthalmology 2009;116(2):297-303.
33. Cugati S, Mitchell P, Rochtchina E, Tan AG, Smith W, Wang JJ. Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 2006;113(11):2020-5.
34. Deeks JJ, Higgins JP, Altman DG, editor(s) . Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
35. Dong LM, Stark WJ, Jefferys JL, Al-Hazzaa S, Bressler SB, Solomon SD, et al. Progression of age-related macular degeneration after cataract surgery. Archives of Ophthalmology 2009;127(11):1412-9.
36. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Survey of Ophthalmology 2006;51(2):137-52.
37. The Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 2004;122(4):564-72.
38. Evans JR. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD000254.pub2]
39. Ferris FL 3rd, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Archives of Ophthalmology 1984;102(11):1640-2.
40. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
41. GRADE Working Group, McMaster University. GRADEpro. Version accessed 14 December 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
42. Higgins JP, Altman DG, Sterne JAC, editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
43. Hiller R, Sperduto RD, Podgor MJ, Wilson PW, Ferris FL 3rd, Colton T, et al. Cigarette smoking and the risk of development of lens opacities. The Framingham studies. Archives of Ophthalmology 1997;115(9):1113-8.
44. Jacques PF, Taylor A, Moeller S, Hankinson SE, Rogers G, Tung W, et al. Long-term nutrient intake and 5-year change in nuclear lens opacities. Archives of Ophthalmology 2005;123(4):517-26.
45. Kaiserman I, Kaiserman N, Elhayany A, Vinker S. Cataract surgery is associated with a higher rate of photodynamic therapy for age-related macular degeneration. Ophthalmology 2007;114(2):278-82.
46. Klein R, Rowland ML, Harris MI. Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology 1995;102(3):371-81.
47. Klein R, Klein BK, Wong TY, Tomany SC, Cruickshanks KJ. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy. Archives of Ophthalmology 2002;120(11):1551-8.
48. Kuo IC, Broman AT, Massof RW, Park W. The impact of cataract surgery on patients from a low-vision clinic. Canadian Journal of Ophthalmology 2011;46(5):391-8.
49. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Archives of Ophthalmology 1982;100(6):912-8.
50. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Archives of Ophthalmology 1991;109(8):1109-14.
51. Ohr M, Kaiser P. Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration. Expert Opinion on Pharmacotherapy 2012;13(4):585-91.
52. Powe NR, Schein OD, Gieser SC, Tielsch JM, Luthra R, Javitt J, et al. Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team. Archives of Ophthalmology 1994;112(2):239-52.
53. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
54. Riaz Y, Mehta JS, Wormald R, Evans JR, Foster A, Ravilla T, et al. Surgical interventions for age-related cataract. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD001323.pub2]
55. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. New England Journal of Medicine 2006;355(14):1419-31.
56. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Archives of Ophthalmology 2006;124(7):995-1001.
57. Shuttleworth GN, Luhishi EA, Harrad RA. Do patients with age-related maculopathy and cataract benefit from cataract surgery?. British Journal of Ophthalmology 1998;82(6):611-6.
58. Sutter FK, Menghini M, Barthelmes D, Fleischhauer JC, Kurz-Levin MM, Bosch MM, et al. Is pseudophakia a risk factor for neovascular age-related macular degeneration?. Investigative Ophthalmology & Visual Science 2007;48(4):1472-5.
59. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Archives of Ophthalmology 1999;117(10):1329-45.
60. Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2. Archives of Ophthalmology 2001;119(2):198-207.
61. D'Amico DJ, Masonson HN, Patel M, Adamis AP, Cunningham ET Jr, Guyer DR, et al. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 2006;113(6):992-1001.
62. Wang JJ, Klein R, Smith W, Klein BEK, Tomany S, Mitchel P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy. Pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology 2003;110(10):1960-7.
63. West SK, Rosenthal FS, Bressler NM, Bressler SB, Munoz B, Fine SL, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Archives of Ophthalmology 1989;107(6):875-9.
64. World Health Organization. Magnitude and causes of visual impairment. Fact Sheet N°282. October 2011. www.who.int/mediacentre/factsheets/fs282/en/index.html (accessed 22 November 2011).
65. Casparis H, Bressler N. Surgery for cataracts in people with age-related macular degeneration. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006757]
66. Casparis H, Lindsley K, Kuo I, Sikder S, Bressler NB. Surgery for cataracts in people with age-related macular degeneration. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD006757.pub2]
67. Casparis H, Lindsley K, Kuo IC, Sikder S, Bressler NM. Surgery for cataracts in people with age-related macular degeneration. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD006757.pub3]